ID: 126806438 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:181520993-181522192 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180656266..180657465) | | |
ID: 122861260 | Sharpr-MPRA regulatory region 10987 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180607522..180607816) | | |
ID: 105373771 | uncharacterized LOC105373771 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180719967..180723649, complement) | | |
ID: 105373770 | uncharacterized LOC105373770 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180566997..180571831, complement) | | |
ID: 105373769 | uncharacterized LOC105373769 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180409532..180432380, complement) | | |
ID: 101669767 | SWI/SNF complex antagonist associated with prostate cancer 1 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (180692104..180916939) | LINC00913, PCAT11, PCAT114 | 615568 |